alexa Efficacy Of Topical Dorzolamide 2% In Diabetic Cystoid Macular Edema
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

10th International Conference on Clinical & Experimental Ophthalmology
November 21-23, 2016 Dubai, UAE

Amani Badawi
Mansoura University, Egypt
ScientificTracks Abstracts: J Clin Exp Ophthalmol
DOI: 10.4172/2155-9570.C1.048
Abstract
Purpose: To determine the effect of a topical dorzolamide 2% on the macular thickness and function in patients with diabetic cystoid macular edema (CME). Setting: Mansoura Ophthalmic Center, Mansoura University, Mansoura, Egypt. Methods: The study was planned as a prospective, non-randomized, controlled and interventional study. A total of 84 diabetic patients (93 eyes) with secondary cystoid macular edema were included in the study. All eyes received topical dorzolamide 2% every 8 hours/day for one month. Changes in best-corrected visual acuity (BCVA), intraocular pressure (IOP), and optical coherence tomography measurements were evaluated at one week, one month and 3 months post-treatment. Results: Mean (logMAR) best-corrected visual acuity pre-treatment and one week, 1 month, and 3 months post-treatment was 1.08±0.26, 1.02±0.28, 0.66±0.24 and 0.87±0.26, respectively. The mean baseline central macular thickness was 535.27 ± 97.4 μm and reduced to 420.87±115.24 μm (21.4% reduction) at one week and 357.43±125.8 μm (33.2% reduction) at one month and then showed slight increase and reached 376.23±134.5 μm (29.7% reduction) at the end of 3 months, but still statistically significantly less than the baseline value. Conclusions: Topical dorzolamide 2% significantly improved BCVA and reduced mean central macular thickness at 3 months. It could be effective, affordable and safe therapy in treating non-refractory diabetic cystoids macular edema.
Biography

Amani Badawi has completed her PhD in 2012 from Mansoura University, Egypt. She has worked as an Assistant Lecturer of Ophthalmology, Mansoura Ophthalmic Center in Egypt from 2006-2012 and as a Lecturer of Ophthalmology in Mansoura Ophthalmic Center in Egypt from 2012 to till date. She has published three papers and has been serving as a Reviewer in two different journals.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version